How Technology Can Address Upcoming Big Pharma Financial Crunch

Through a wide-ranging discussion, Corrigan outlines how clinical trial technology must evolve to address the financial pressures created by the Inflation Reduction Act. He emphasizes the critical role of flexible, patient-centric solutions and standardized processes to accelerate drug development timelines. The interview explores emerging trends including AI integration, unified data ecosystems, and success metrics beyond traditional cost and timeline measurements. Corrigan shares insights on maintaining compliance across global regulatory landscapes while empowering stakeholders throughout the clinical trial process. His vision centers on creating intuitive technology that enhances efficiency without compromising quality or scientific advancement.